PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

MicroRNAs can convert normal cells into cancer promoters

Study pinpoints new targets for ovarian cancer treatment

2012-11-21
(Press-News.org) Unraveling the mechanism that ovarian cancer cells use to change normal cells around them into cells that promote tumor growth has identified several new targets for treatment of this deadly disease.

In the December issue of the American Association for Cancer Research journal Cancer Discovery, a team or researchers from the University of Chicago Medicine and Northwestern University Feinberg School of Medicine show that ovarian cancer cells induce nearby cells to alter their production of three microRNAs—small strands of genetic material that are important regulators of gene expression.

By changing gene expression, microRNAs can modify a cell's function. In this case, they convert normal, healthy fibroblasts into cancer-associated fibroblasts (CAFs). These CAFs pump out chemical signals telling cancer cells to multiply, invade healthy tissues and travel to distant sites in the abdomen. Importantly, by reversing the microRNA signals the researchers were able to cause CAFs to revert to normal fibroblasts.

"These cancer-supporting cells provide a novel and appealing treatment target," said one of the lead authors of the study Ernst Lengyel, MD, PhD, professor in the department of obstetrics and gynecology at the University of Chicago. "Cancer cells mutate rapidly, which enables them to develop drug resistance. But cancer-associated fibroblasts are genetically stable," he said. "Their harmful behavior is driven by the microRNAs. Inhibiting those signals is a new way to fight this disease. It disrupts the cancer's support system and is unlikely to evolve resistance."

"With ovarian cancer," Lengyel added, "we desperately need new treatments. "There have been no new approaches introduced into the clinic for years, and thus no major improvements in patient survival."

Fibroblasts are the primary cellular component of connective tissue. They provide the structural framework for other tissues and aid in wound healing. When fibroblast-dense tissues are infiltrated by cancer cells, however, "intimate cross-talk between fibroblasts and cancer cells" can covert them to cancer-associated fibroblasts, Lengyel said, "shifting them into a new role."

"Only a few years ago scientists learned how to reprogram normal cells into cells that can give rise to any cell type in the body," said the second lead author on the study Marcus Peter, PhD, professor of medicine at Northwestern University Feinberg School of Medicine. "Our work demonstrates that cancer cells also have the ability to reprogram cells in their environment into cells that support their growth and that this process involves microRNAs."

The researchers found that cancer cells caused normal fibroblasts to reduce production of two microRNAs, miR-31 and miR-214, and to increase production of miR-155. Since microRNAs usually block gene expression, reduced levels increased expression of several of their target genes. Many of those genes are involved in the production of the chemical signals associated with CAFs.

The most highly upregulated such signal, known as CCL5, is a "key tumor-promoting factor," the authors show. When human ovarian cancer cells and CAFs were co-injected into mice, the tumor cells soon replaced normal ovarian structures. Antibodies that neutralized CCL5 inhibited this augmented growth.

"One strength of our study is that we used tumor cells and CAFs from patients, rather than cell lines," said Lengyel, a gynecologic oncologist who specializes in the surgical treatment of women with ovarian cancer. "Our model system is as close as possible to the real situation."

"Therapeutic approaches targeting microRNAs in cancer cells are under development," added Peter. "Our work suggests that it might be possible to modify microRNA expression in cancer-associated fibroblasts for therapeutic benefit."

### The Ovarian Cancer Research Fund supported this study. Additional authors include Anirban Mitra, Marion Zillhardt and Payal Tiwari from the University of Chicago, and Youjia Hua and Andrea Murmann from Northwestern University.



ELSE PRESS RELEASES FROM THIS DATE:

Early birds had an old-school version of wings

2012-11-21
In comparison to modern birds, the prehistoric Archaeopteryx and bird-like dinosaurs before them had a more primitive version of a wing. The findings, reported on November 21 in Current Biology, a Cell Press publication, lend support to the notion that birds are the descendants of gliding dinosaurs that spent much of their days in the trees. "By studying fossils carefully, we are now able to start piecing together how the wing evolved," said Nicholas Longrich of Yale University. "Before, it seemed that we had more or less modern wings from the Jurassic onwards. Now it's ...

Drug resistance biomarker could improve cancer treatment

2012-11-21
Cancer therapies often have short-lived benefits due to the emergence of genetic mutations that cause drug resistance. A key gene that determines resistance to a range of cancer drugs has been reported in a study published by Cell Press November 21st in the journal Cell. The study reveals a biomarker that can predict responses to cancer drugs and offers a strategy to treat drug-resistant tumors based on their genetic signature. "We need to understand the mechanisms of drug resistance to effectively prevent it from occurring in the first place," says senior study author ...

Biomarking time

2012-11-21
Women live longer than men. Individuals can appear or feel years younger – or older – than their chronological age. Diseases can affect our aging process. When it comes to biology, our clocks clearly tick differently. In a new study, researchers at the University of California, San Diego School of Medicine, with colleagues elsewhere, describe markers and a model that quantify how aging occurs at the level of genes and molecules, providing not just a more precise way to determine how old someone is, but also perhaps anticipate or treat ailments and diseases that come ...

Brain waves encode rules for behavior

2012-11-21
CAMBRIDGE, MA -- One of the biggest puzzles in neuroscience is how our brains encode thoughts, such as perceptions and memories, at the cellular level. Some evidence suggests that ensembles of neurons represent each unique piece of information, but no one knows just what these ensembles look like, or how they form. A new study from researchers at MIT and Boston University (BU) sheds light on how neural ensembles form thoughts and support the flexibility to change one's mind. The research team, led by Earl Miller, the Picower Professor of Neuroscience at MIT, identified ...

A*STAR scientists identify potential drug target for inflammatory diseases including cancers

2012-11-21
A*STAR scientists have identified the enzyme, telomerase, as a cause of chronic inflammation in human cancers. Chronic inflammation is now recognized as a key underlying cause for the development of many human cancers, autoimmune disorders, neurodegenerative diseases, and metabolic diseases such as diabetes. This enzyme, which is known to be responsible for providing cancer cells the endless ability to divide, is now found to also jumpstart and maintain chronic inflammation in cancers. In identifying this enzyme, inflammation can be prevented or reduced, and the common ...

Feature package of Congo Basin forest photos, stories & videos

2012-11-21
Stretching across central Africa, the Congo Basin forest is the second largest tract of rainforest in the world and a lifeline for more than 60 million people – providing food and income for many remote communities, storing huge amounts of carbon, supporting unique ecosystems and regulating the flow of the major rivers across Central Africa. Yet the Congo's forests are being cleared at an alarming rate amid global demand for the continent's minerals, energy and wood resources. Current methods and rates of extracting these resources are unsustainable and threatening the ...

Kidney tumors have a mind of their own

2012-11-21
TORONTO, Nov. 21, 2012-- New research has found there are several different ways that kidney tumours can achieve the same result – namely, grow. Scientists have been trying to figure out how different people have kidney tumours with the same histology, or shape, although the genetic changes can vary among individual tumours. Solving that puzzle could have implications for the diagnosis and treatment if kidney cancer, which has 35 per cent mortality rate and is becoming more common. Despite advances in early detection and treatment, the mortality rate hasn't changed in ...

The most popular TV series among youngsters in Spain recreates violence

2012-11-21
Published in the Comunicación journal, a study conducted by the University of Seville analyses violence content in Spanish TV series. It concludes that Telecinco's Sin tetas no hay paraíso is the most violent of the five studied. Despite the fact that other series have more scenes or minutes of violence, according to the study, the Telecinco series is more powerful in its transmission of values that are more detrimental to youngsters in terms of their perception of aggressive behaviour and its consequences. Sara González, the author of the study, explains to SINC ...

Flower power to purge poison and produce platinum

Flower power to purge poison and produce platinum
2012-11-21
A consortium of researchers led by WMG at the University of Warwick are to embark on a £3 million research programme called "Cleaning Land for Wealth" (CL4W), that will use a common class of flower to restore poisoned soils while at the same time producing perfectly sized and shaped nano sized platinum and arsenic nanoparticles for use in catalytic convertors, cancer treatments and a range of other applications. A "Sandpit" exercise organised by the Engineering and Physical Sciences Research Council (EPSRC) allowed researchers from WMG (Warwick Manufacturing group) at ...

Researchers detail the migrations of the wood wasp Sirex noctilio

2012-11-21
In order to find out about its migrations, various research centres in South Africa, Sweden, Canada, Chile, Australia, Spain, Argentina and Switzerland have conducted research detailing its routes and expansion periods. A significant new fact has emerged and it is that the wasps returning to Europe from Chile and South Africa have undergone a genetic micro-evolution which makes them more resistant to their natural European enemy, a nematode that sterilises them. The Sirex noctilio wasp is regarded as a secondary pest in Europe because in this geographical area there is ...

LAST 30 PRESS RELEASES:

Science briefing: An update on GLP-1 drugs for obesity

Lower doses of immunotherapy for skin cancer give better results

Why didn’t the senior citizen cross the road? Slower crossings may help people with reduced mobility

ASH 2025: Study suggests that a virtual program focusing on diet and exercise can help reduce side effects of lymphoma treatment

A sound defense: Noisy pupae puff away potential predators

Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy

Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

New findings support a chemo-free approach for treating Ph+ ALL

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

[Press-News.org] MicroRNAs can convert normal cells into cancer promoters
Study pinpoints new targets for ovarian cancer treatment